Urinating more in winter is common, but not always harmless. A urologist explains why men experience frequent urination in ...

ENYO Pharma ("ENYO"), a clinical-stage biopharmaceutical company developing innovative therapies for kidney diseases, today ...

Preventive health check-ups in 2026 are essential for early disease detection and long-term well-being. Experts recommend ...

ASN Kidney Week, held in November, featured leading-edge science in kidney care, with evidence supporting new drugs to treat ...

Post hoc trial findings support aprocitentan’s potential cardiovascular and kidney-protective effects in patients with chronic kidney disease (CKD) with resistant hypertension.

The updated guideline addresses rapid advances in pharmacologic management, balancing use of newer, older drugs.

Medically reviewed by Jamin Brahmbhatt, MD Key Takeaways Complement 3 glomerulopathy (C3G) is diagnosed with a combination of ...

Medically reviewed by Matthew Wosnitzer, MD Key Takeaways IgA nephropathy is diagnosed through a combination of clinical ...

Explore the stages and prevalence of chronic kidney disease, highlighting risk factors and the importance of early detection ...

Recommendations include use of ACE-I or ARB to slow CKD progression in patients with hypertension and albuminuria.

This review synthesizes clinical, genetic, and mechanistic evidence showing that suPAR and related uPAR fragments are ...

Jillian Kubala, MS, is a registered dietitian based in Westhampton, NY. Jillian uses a unique and personalized approach to help her clients achieve optimal wellness through nutrition and lifestyle ...